MTHFR C677T基因多态性及同型半胱氨酸水平与高血压患者血压变异性的关系
The Relationship between MTHFR C677T Gene Polymorphism and Homocysteine Levels and Blood Pressure Variability in Hypertensive Patients
DOI: 10.12677/acm.2025.152511, PDF,   
作者: 孙寿锦, 周 弛:青岛大学附属医院市南区心血管内科,山东 青岛;青岛大学青岛医学院,山东 青岛;廉哲勋*:青岛大学附属医院市南区心血管内科,山东 青岛
关键词: 同型半胱氨酸亚甲基四氢叶酸还原酶基因多态性动态血压指标Homocysteine Methylenetetrahydrofolate Reductase Gene Polymorphism Ambulatory Blood Pressure Indices
摘要: 目的:本研究探讨MTHFR基因C677T多态性及同型半胱氨酸与高血压患者血压变异性之间的关系。方法:选取2023年1月至2024年10月期间,前往青岛大学附属医院心内科就诊的101例左心室射血分数正常的原发性高血压患者。采用24动态血压检测仪分别测量患者各血压指标[24 h收缩压(SBP)、24 h舒张压(DBP)、日间平均收缩压(dSBP)、日间平均舒张压(dDBP)、夜间平均收缩压(nSBP)、夜间平均舒张压(nDBP)]、血压变异性指标[24 h收缩压变异系数(SBPV)、24 h舒张压变异系数(DBPV)、日间平均收缩压变异系数(dSBPV)、日间平均舒张压变异系数(dDBPV)、夜间平均收缩压变异系数(nSBPV)、夜间平均舒张压变异系数(nDBPV)]及特殊时间段血压指标(夜间血压下降率及清晨收缩压和舒张压)。于清晨空腹时抽取受试者静脉血样,通过全自动生化分析仪检测受试者的甘油三酯(TG)、胆固醇(TC)、低密度脂蛋白(LDL-c)、高密度脂蛋白(HDL-c)、转氨酶、血清肌酐(Cr)和血糖(空腹) (FBG)水平,并通过PCR荧光法检测MTHFR C677T基因型。根据不同基因型,将受试者分为CC (20例)、CT (58例)和TT (23例)组,以比较各组常规生化指标、同型半胱氨酸(Hcy)及动态血压指标差异。此外,对存在叶酸代谢障碍的TT型患者,按推荐剂量服用0.8 mg/天叶酸,连续6个月后再次测量其动态血压指标,以比较应用前后的变化。结果:共纳入符合标准的原发性高血压患者,各组年龄(64.95 ± 9.88 vs. 59.93 ± 11.85 vs. 59.87 ± 7.95, P = 0.175),性别比例(男:45% vs. 44.8% vs. 43.5%,P = 0.993),以及甘油三酯(TG)、胆固醇(TC)等一般资料均无统计学意义(P > 0.05)。然而,与Hcy水平存在显著差异(8.09 (7.66~8.52) vs. 13.00 (11.40~13.90) vs. 21.20 (19.00~22.30), P < 0.05)。在动态血压各项均值指标中,TT组相较于CT组及CC组存在显著差异(P < 0.05)。此外,在动态血压的变异系数,以及特定时间段如夜间血压下降率与清晨血压指标方面,TT组亦显示出显著差异(P < 0.05)。结论:MTHFR C677T基因多态性与同型半胱氨酸(Hcy)水平以及动态血压均值和变化指数显著相关。
Abstract: Objective: This study aimed to explore the relationship between MTHFR gene C677T polymorphism, homocysteine, and blood pressure variability in patients with hypertension. Methods: A total of 101 patients with primary hypertension and normal left ventricular ejection fraction who visited the Department of Cardiology of the Affiliated Hospital of Qingdao University from January 2023 to October 2024 were selected. Blood pressure indicators [24-hour systolic blood pressure (SBP), 24-hour diastolic blood pressure (DBP), daytime average systolic blood pressure (dSBP), daytime average diastolic blood pressure (dDBP), nighttime average systolic blood pressure (nSBP), and nighttime average diastolic blood pressure (nDBP)], blood pressure variability indicators [24-hour systolic blood pressure variability coefficient (SBPV), 24-hour diastolic blood pressure variability coefficient (DBPV), daytime average systolic blood pressure variability coefficient (dSBPV), daytime average diastolic blood pressure variability coefficient (dDBPV), nighttime average systolic blood pressure variability coefficient (nSBPV), and nighttime average diastolic blood pressure variability coefficient (nDBPV)], and blood pressure indicators at specific time periods (nighttime blood pressure decline rate and morning systolic and diastolic blood pressure) were measured using a 24-hour ambulatory blood pressure monitor. Venous blood samples were collected from the subjects in the morning on an empty stomach, and the levels of triglycerides (TG), cholesterol (TC), low-density lipoprotein (LDL-c), high-density lipoprotein (HDL-c), transaminases, serum creatinine (Cr), and fasting blood glucose (FBG) were detected using an automatic biochemical analyzer. The MTHFR C677T genotype was detected by PCR fluorescence method. The subjects were divided into CC (20 cases), CT (58 cases), and TT (23 cases) groups according to different genotypes to compare the differences in conventional biochemical indicators, homocysteine (Hcy), and ambulatory blood pressure indicators among the groups. In addition, for patients with TT type and folate metabolism disorders, 0.8 mg/day of folic acid was administered for 6 consecutive months, and their ambulatory blood pressure indicators were measured again to compare the changes before and after application. Results: A total of 101 patients with primary hypertension who met the criteria were included. There were no statistically significant differences in age (64.95 ± 9.88 vs. 59.93 ± 11.85 vs. 59.87 ± 7.95, P = 0.175), gender ratio (male: 45% vs. 44.8% vs. 43.5%, P = 0.993), and general data such as triglycerides (TG) and cholesterol (TC) among the groups (P > 0.05). However, there were significant differences in Hcy levels (8.09 (7.66~8.52) vs. 13.00 (11.40~13.90) vs. 21.20 (19.00~22.30), P < 0.05). In the mean values of ambulatory blood pressure indicators, the TT group showed significant differences compared with the CT group and the CC group (P < 0.05). In addition, in the variability coefficients of ambulatory blood pressure and specific time periods such as nighttime blood pressure decline rate and morning blood pressure indicators, the TT group also showed significant differences (P < 0.05). Conclusion: MTHFR C677T gene polymorphism is significantly associated with homocysteine (Hcy) levels, mean values of ambulatory blood pressure, and variability indices.
文章引用:孙寿锦, 周弛, 廉哲勋. MTHFR C677T基因多态性及同型半胱氨酸水平与高血压患者血压变异性的关系[J]. 临床医学进展, 2025, 15(2): 1566-1580. https://doi.org/10.12677/acm.2025.152511

参考文献

[1] de Courson, H., Ferrer, L., Barbieri, A., Tully, P.J., Woodward, M., Chalmers, J., et al. (2021) Impact of Model Choice When Studying the Relationship between Blood Pressure Variability and Risk of Stroke Recurrence. Hypertension, 78, 1520-1526. [Google Scholar] [CrossRef] [PubMed]
[2] 石雪丽, 赵光宇, 刘敬敏. 氨氯地平阿托伐他汀对高血压合并冠心病患者心血管活性肽、炎症因子及血管内皮功能的影响[J]. 中国循证心血管医学杂志, 2021, 13(4): 438-442.
[3] Hu, L., Bi, C., Liu, L., Song, Y., Zhang, Y., Wang, B., et al. (2021) Association between Baseline Brachial-Ankle Pulse Wave Velocity and Short-Term Risk of First Stroke among Chinese Hypertensive Adults. Journal of Human Hypertension, 36, 1085-1091. [Google Scholar] [CrossRef] [PubMed]
[4] 钟欣静, 黄翠娟, 林蓓佑, 等. H型高血压病人同型半胱氨酸与血压变异性和血尿酸的相关性[J]. 中西医结合心脑血管病杂志, 2020, 18(6): 948-951.
[5] Liao, S., Guo, S., Ma, R., He, J., Yan, Y., Zhang, X., et al. (2022) Association between Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and H‐Type Hypertension: A Systematic Review and Meta‐Analysis. Annals of Human Genetics, 86, 278-289. [Google Scholar] [CrossRef] [PubMed]
[6] 张轶英. 血浆同型半胱氨酸与D二聚体检测在老年高血压和高血压并脑梗死患者中的临床意义[J]. 血栓与止血学, 2022, 28(1): 38-39+41.
[7] Kikuya, M., Hozawa, A., Ohokubo, T., Tsuji, I., Michimata, M., Matsubara, M., et al. (2000) Prognostic Significance of Blood Pressure and Heart Rate Variabilities: The Ohasama Study. Hypertension, 36, 901-906. [Google Scholar] [CrossRef] [PubMed]
[8] Sega, R., Corrao, G., Bombelli, M., Beltrame, L., Facchetti, R., Grassi, G., et al. (2002) Blood Pressure Variability and Organ Damage in a General Population: Results from the PAMELA Study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension, 39, 710-714. [Google Scholar] [CrossRef] [PubMed]
[9] Fagard, R. (1992) Hypertensive Heart Disease: Pathophysiology and Clinical and Prognostic Consequences. Journal of Cardiovascular Pharmacology, 19, 59-66. [Google Scholar] [CrossRef
[10] Goldstein, I.B., Bartzokis, G., Guthrie, D. and Shapiro, D. (2002) Ambulatory Blood Pressure and Brain Atrophy in the Healthy Elderly. Neurology, 59, 713-719. [Google Scholar] [CrossRef] [PubMed]
[11] Ikeda, Y., Handa, M., Kawano, K., Kamata, T., Murata, M., Araki, Y., et al. (1991) The Role of Von Willebrand Factor and Fibrinogen in Platelet Aggregation under Varying Shear Stress. Journal of Clinical Investigation, 87, 1234-1240. [Google Scholar] [CrossRef] [PubMed]
[12] Kario, K., Mitsuhashi, T. and Shimada, K. (2002) Neurohumoral Characteristics of Older Hypertensive Patients with Abnormal Nocturnal Blood Pressure Dipping. American Journal of Hypertension, 15, 531-537. [Google Scholar] [CrossRef] [PubMed]
[13] Fowler, B. (2005) Homocysteine: Overview of Biochemistry, Molecular Biology, and Role in Disease Processes. Seminars in Vascular Medicine, 5, 77-86. [Google Scholar] [CrossRef] [PubMed]
[14] Goyette, P., Christensen, B., Rosenblatt, D.S., et al. (1996) Severe and Mild Mutations in Cis for the Methylenetetrahydrofolate Reductase (MTHFR) Gene, and Description of Five Novel Mutations in MTHFR. The American Journal of Human Genetics, 59, 1268-1275.
[15] Goyette, P., Sumner, J.S., Milos, R., Duncan, A.M.V., Rosenblatt, D.S., Matthews, R.G., et al. (1994) Human Methylenetetrahydrofolate Reductase: Isolation of cDNA, Mapping and Mutation Identification. Nature Genetics, 7, 195-200. [Google Scholar] [CrossRef] [PubMed]
[16] Goyette, P., Pai, A., Milos, R., Frosst, P., Tran, P., Chen, Z., et al. (1998) Gene Structure of Human and Mouse Methylenetetrahydrofolate Reductase (MTHFR). Mammalian Genome, 9, 652-656. [Google Scholar] [CrossRef] [PubMed]
[17] Liew, S. and Gupta, E.D. (2015) Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism: Epidemiology, Metabolism and the Associated Diseases. European Journal of Medical Genetics, 58, 1-10. [Google Scholar] [CrossRef] [PubMed]
[18] 李建平, 卢新政, 霍勇, 等. H型高血压诊断与治疗专家共识[J]. 中国医学前沿杂志(电子版), 2016, 8(5): 23-28.
[19] Kjeldsen, S.E., Julius, S., Hedner, T. and Hansson, L. (2001) Stroke Is More Common than Myocardial Infarction in Hypertension: Analysis Based on 11 Major Randomized Intervention Trials. Blood Pressure, 10, 190-192. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, J., Kario, K., Park, J. and Chen, C. (2017) Morning Blood Pressure Monitoring in the Management of Hypertension. Journal of Hypertension, 35, 1554-1563. [Google Scholar] [CrossRef] [PubMed]
[21] Yu, H.H., Zhang, W.L. and Shi, J.P. (2011) Relationship between Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Susceptibility of Ischemic Stroke: A Meta-Analysis. Chinese Journal of Preventive Medicine, 91, 2060-2064.
[22] Banerjee, I., Gupta, V. and Ganesh, S. (2006) Association of Gene Polymorphism with Genetic Susceptibility to Stroke in Asian Populations: A Meta-Analysis. Journal of Human Genetics, 52, 205-219. [Google Scholar] [CrossRef] [PubMed]
[23] Xuan, C., Bai, X., Gao, G., Yang, Q. and He, G. (2011) Association between Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR) C677T and Risk of Myocardial Infarction: A Meta-Analysis for 8,140 Cases and 10,522 Controls. Archives of Medical Research, 42, 677-685. [Google Scholar] [CrossRef] [PubMed]
[24] Heifetz, E.M. and Birk, R.Z. (2014) MTHFR C677T Polymorphism Affects Normotensive Diastolic Blood Pressure Independently of Blood Lipids. American Journal of Hypertension, 28, 387-392. [Google Scholar] [CrossRef] [PubMed]
[25] Gomezangelats, E., Delasierra, A., Sierra, C., Parati, G., Mancia, G. and Coca, A. (2004) Blood Pressure Variability and Silent Cerebral Damage in Essential Hypertension. American Journal of Hypertension, 17, 696-700. [Google Scholar] [CrossRef] [PubMed]
[26] Kario, K. and Pickering, T.G. (2000) Blood Pressure Variability in Elderly Patients. The Lancet, 355, 1645-1646. [Google Scholar] [CrossRef] [PubMed]